Predict your next investment

Population Genetics Technologies company logo
HEALTHCARE | Drug Discovery
popgentech.com

See what CB Insights has to offer

Founded Year

2005

Stage

Series B | Alive

Total Raised

$18.3M

Last Raised

$5.7M | 10 yrs ago

About Population Genetics Technologies

Population Genetics Technologies (PGT) develops technologies that aim to transform the economic viability of performing large scale genetic population studies and allow the detection and characterization of rare allelic variants increasingly thought to play a major role in the development of many disease states.

Population Genetics Technologies Headquarter Location

Cambridge

CB22 3AQ,

United Kingdom

(+440) 122-349-7357

Latest Population Genetics Technologies News

Population Genetics Technologies Ltd Medical Equipment Deals and Alliances Profile Report Updated 07092018 Prices from USD $250

Sep 28, 2018

Population Genetics Technologies Ltd Medical Equipment Deals and Alliances Profile [Report Updated: 07092018] Prices from USD $250 06:18 EDT 28 Sep 2018 | BioPortfolio Reports Summary Population Genetics Technologies Ltd Population Genetics, a subsidiary of Agilent Technologies Inc is a biotechnology company. The company commercialize nucleic acid biochemistry tools and approaches. Its intellectual property assets include method for normalizing a nucleic acid sample, method for fragmenting a nucleic acid for sequencing , method for identifying minority variants in a sample, methods and compositions for isolating nucleic acid sequence variants, multiplexed analytical platform and others. The company currently markets certain intellectual property families within its portfolio, targeting companies in the molecular diagnostic and broader sequencing and life science tools sectors. Population Genetics is headquartered in Cambridge, the UK. Population Genetics Technologies Ltd Medical Equipment Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Medical eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Population Genetics Technologies

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Population Genetics Technologies is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

5,238 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Population Genetics Technologies Patents

Population Genetics Technologies has filed 39 patents.

The 3 most popular patent topics include:

  • Biotechnology
  • DNA
  • Genetics
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/26/2014

2/23/2021

Molecular biology, Genetics, DNA sequencing, DNA, Biotechnology

Grant

Application Date

11/26/2014

Grant Date

2/23/2021

Title

Related Topics

Molecular biology, Genetics, DNA sequencing, DNA, Biotechnology

Status

Grant

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.